Canadian drugmaker Valeant Pharmaceuticals said Friday it will increase the list prices of products in some of its portfolios by 2 percent to 9 percent.
» Read More
Dominance in the genetic-sequencing market is causing Illumina's decline. A company can be too good and fast at exploiting new technology. » Read More
GoBabyGo modifies toys so that children with even the most severe mobility issues can use them. The idea grabbed Mattel's attention. » Read More
The toy industry is booming again, but kids with special needs are left out of the fun. CNBC's Dina Gusovsky reports on a doctor whose toys can help. » Read More
Get the best of CNBC in your inbox
Dan Mangan is a reporter covering health care for CNBC.com.
Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.
Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.